4-Cholesten-3-one

4-Cholesten-3-one is a lipid of Sterol Lipids (ST) class. 4-cholesten-3-one is associated with abnormalities such as Dehydration, Xanthomatosis, Cerebrotendinous, Peripheral Neuropathy, L.mexicana and Xanthoma. The involved functions are known as CYP27A1activity, 25-hydroxycholesterol 7alpha-hydroxylase activity, Biochemical Pathway, Anabolism and Oxidation. 4-cholesten-3-one often locates in Mitochondria, Liver, Body tissue, Hepatic, Mitochondria and Endothelium of artery. The associated genes with 4-Cholesten-3-one are P4HTM gene, tryptones and Regulon. The related lipids are Cholestenones, 7-hydroxy-4-cholesten-3-one, cholest-4-en-3-one, 25-hydroxycholesterol and 24-hydroxycholesterol.

Cross Reference

Introduction

To understand associated biological information of 4-Cholesten-3-one, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 4-Cholesten-3-one?

4-Cholesten-3-one is suspected in Dehydration, Xanthomatosis, Cerebrotendinous, Peripheral Neuropathy, L.mexicana, Xanthoma, Rare Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with 4-Cholesten-3-one

Lipid pathways are not clear in current pathway databases. We organized associated pathways with 4-Cholesten-3-one through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 4-Cholesten-3-one?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 4-Cholesten-3-one?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 4-Cholesten-3-one?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 4-Cholesten-3-one?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 4-Cholesten-3-one?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 4-Cholesten-3-one

Download all related citations
Per page 10 20 50 100 | Total 397
Authors Title Published Journal PubMed Link
Cabeza M et al. New progesterone derivatives as inhibitors of 5alpha-reductase enzyme and prostate cancer cell growth. 2006 J Enzyme Inhib Med Chem pmid:17059168
Stine KJ et al. Interaction of the glycoalkaloid tomatine with DMPC and sterol monolayers studied by surface pressure measurements and Brewster angle microscopy. 2006 J Phys Chem B pmid:17078662
Gilliver SC et al. Androgens modulate the inflammatory response during acute wound healing. 2006 J. Cell. Sci. pmid:16449322
Huang YF et al. One new anthraquinone from marine Streptomyces sp. FX-58. 2006 Nat. Prod. Res. pmid:17127510
Woollett LA et al. Micellar solubilisation of cholesterol is essential for absorption in humans. 2006 Gut pmid:16407385
Rebolj K et al. Steroid structural requirements for interaction of ostreolysin, a lipid-raft binding cytolysin, with lipid monolayers and bilayers. 2006 Biochim. Biophys. Acta pmid:16857161
Rojo L et al. Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease. 2006 J. Biomed. Biotechnol. pmid:17047312
Lim L et al. Structural and kinetic analyses of the H121A mutant of cholesterol oxidase. 2006 Biochem. J. pmid:16856877
Finn DA et al. A new look at the 5alpha-reductase inhibitor finasteride. 2006 CNS Drug Rev pmid:16834758
Zhu YS and Cai LQ Effects of male sex hormones on gender identity, sexual behavior, and cognitive function. 2006 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:16706106
Maria McCrohan A et al. Effects of the dual 5 alpha-reductase inhibitor dutasteride on apoptosis in primary cultures of prostate cancer epithelial cells and cell lines. 2006 Cancer pmid:16703599
Rouquette-Jazdanian AK et al. Revaluation of the role of cholesterol in stabilizing rafts implicated in T cell receptor signaling. 2006 Cell. Signal. pmid:15925486
Liu J et al. 5alpha-reductase inhibitory effect of triterpenoids isolated from Ganoderma lucidum. 2006 Biol. Pharm. Bull. pmid:16462054
Naslund MJ et al. Managing enlarged prostate in primary care. 2006 Int. J. Clin. Pract. pmid:17109668
Kim CI et al. Long-term results of medical treatment in benign prostatic hyperplasia. 2006 Urology pmid:17095071
Hall MC The effect of oxysterols, individually and as a representative mixture from food, on in vitro cultured bovine ovarian granulosa cells. 2006 Mol. Cell. Biochem. pmid:16983501
Norg RJ et al. A decision aid for GPs for the treatment of elderly male patients with lower urinary tract symptoms (LUTS). 2006 Fam Pract pmid:16971394
Ekinci S et al. Sigmoid colon vaginoplasty in children. 2006 Eur J Pediatr Surg pmid:16909357
Stottrup BL and Keller SL Phase behavior of lipid monolayers containing DPPC and cholesterol analogs. 2006 Biophys. J. pmid:16461392
Marks LS et al. The interpretation of serum prostate specific antigen in men receiving 5alpha-reductase inhibitors: a review and clinical recommendations. 2006 J. Urol. pmid:16890642
Paris F et al. Increased serum estrogenic bioactivity in three male newborns with ambiguous genitalia: a potential consequence of prenatal exposure to environmental endocrine disruptors. 2006 Environ. Res. pmid:16274687
Beattie ME et al. Sterol structure determines miscibility versus melting transitions in lipid vesicles. 2005 Biophys. J. pmid:15951379
Iranmanesh A and Veldhuis JD Combined inhibition of types I and II 5 alpha-reductase selectively augments the basal (nonpulsatile) mode of testosterone secretion in young men. 2005 J. Clin. Endocrinol. Metab. pmid:15811930
Bratoeff E et al. Recent advances in the chemistry and pharmacological activity of new steroidal antiandrogens and 5 alpha-reductase inhibitors. 2005 Curr. Med. Chem. pmid:15853706
Pérez-Ornelas V et al. New 5alpha-reductase inhibitors: in vitro and in vivo effects. 2005 Steroids pmid:15763601
Pucadyil TJ et al. Membrane cholesterol oxidation inhibits ligand binding function of hippocampal serotonin(1A) receptors. 2005 Biochem. Biophys. Res. Commun. pmid:15850776
Borst SE et al. Inhibition of 5alpha-reductase blocks prostate effects of testosterone without blocking anabolic effects. 2005 Am. J. Physiol. Endocrinol. Metab. pmid:15367394
Hammer F et al. Sex steroid metabolism in human peripheral blood mononuclear cells changes with aging. 2005 J. Clin. Endocrinol. Metab. pmid:16091484
Wakisaka N et al. Effectiveness of finasteride on patients with male pattern baldness who have different androgen receptor gene polymorphism. 2005 J. Investig. Dermatol. Symp. Proc. pmid:16382684
Livingstone DE et al. Increased A-ring reduction of glucocorticoids in obese Zucker rats: effects of insulin sensitization. 2005 Obes. Res. pmid:16222053
Caldinelli L et al. Dissecting the structural determinants of the stability of cholesterol oxidase containing covalently bound flavin. 2005 J. Biol. Chem. pmid:15817448
Evans CP et al. An evidence-based approach to understanding the pharmacological class effect in the management of prostatic diseases. 2005 BJU Int. pmid:15794775
Ellis JA et al. Androgenic correlates of genetic variation in the gene encoding 5alpha-reductase type 1. 2005 J. Hum. Genet. pmid:16155734
Wiebe JP et al. The role of progesterone metabolites in breast cancer: potential for new diagnostics and therapeutics. 2005 J. Steroid Biochem. Mol. Biol. pmid:15860263
Matthiesson KL et al. Novel male hormonal contraceptive combinations: the hormonal and spermatogenic effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist. 2005 J. Clin. Endocrinol. Metab. pmid:15509637
Panter BU et al. 5alpha-reductase in human embryonic kidney cell line HEK293: evidence for type II enzyme expression and activity. 2005 Mol. Cell. Biochem. pmid:15792368
Puglielli L et al. Alzheimer disease beta-amyloid activity mimics cholesterol oxidase. 2005 J. Clin. Invest. pmid:16127459
Sandhu JS and Vaughan ED Combination therapy for the pharmacological management of benign prostatic hyperplasia: rationale and treatment options. 2005 Drugs Aging pmid:16323969
Lewis JG et al. Circulating levels of isoflavones and markers of 5alpha-reductase activity are higher in Japanese compared with New Zealand males: what is the role of circulating steroids in prostate disease? 2005 Steroids pmid:16137729
Barocas DA et al. Five-alpha-reductase expression in benign and malignant urothelium: correlation with disease characteristics and outcome. 2005 Urology pmid:16286153
Andriole G et al. The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledge. 2005 J. Urol. pmid:16280736
Ordyan NE and Pivina SG Effects of prenatal stress on the activity of an enzyme involved in neurosteroid synthesis during the "critical period" of sexual differentiation of the brain in male rats. 2005 Neurosci. Behav. Physiol. pmid:16270175
Kiyokage E et al. Localization of 5alpha-reductase in the rat main olfactory bulb. 2005 J. Comp. Neurol. pmid:16261538
Tiwari A et al. Benign prostatic hyperplasia: an insight into current investigational medical therapies. 2005 Expert Opin Investig Drugs pmid:16255676
Fujita R et al. Anti-androgenic activities of Ganoderma lucidum. 2005 J Ethnopharmacol pmid:16029938
Rosati F et al. 5alpha-Reductase activity in Lycopersicon esculentum: cloning and functional characterization of LeDET2 and evidence of the presence of two isoenzymes. 2005 J. Steroid Biochem. Mol. Biol. pmid:15993049
Gorin RE et al. Effects of finasteride on chronic and acute ethanol withdrawal severity in the WSP and WSR selected lines. 2005 Alcohol. Clin. Exp. Res. pmid:15976519
Monte MJ et al. Transient changes in the expression pattern of key enzymes for bile acid synthesis during rat liver regeneration. 2005 Biochim. Biophys. Acta pmid:15904869
Vallarino M et al. Ontogeny of 3 beta-hydroxysteroid dehydrogenase and 5 alpha-reductase in the frog brain. 2005 Ann. N. Y. Acad. Sci. pmid:15891098
Rho SS et al. The hair growth promoting effect of Asiasari radix extract and its molecular regulation. 2005 J. Dermatol. Sci. pmid:15862941
Luu-The V et al. Quantitative appreciation of steroidogenic gene expression in mouse tissues: new roles for type 2 5alpha-reductase, 20alpha-hydroxysteroid dehydrogenase and estrogen sulfotransferase. 2005 J. Steroid Biochem. Mol. Biol. pmid:15860270
Monte MJ et al. Changes in the expression of genes related to bile acid synthesis and transport by the rat liver during hepatocarcinogenesis. 2005 Clin. Sci. pmid:15853769
Souverein PC et al. Treatment of benign prostatic hyperplasia and occurrence of prostatic surgery and acute urinary retention: a population-based cohort study in the Netherlands. 2005 Eur. Urol. pmid:15774250
Haeffner F et al. Model studies of cholesterol and ascorbate oxidation by copper complexes: relevance to Alzheimer's disease beta-amyloid metallochemistry. 2005 J. Inorg. Biochem. pmid:16271394
Festuccia C et al. Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells. 2005 J. Cancer Res. Clin. Oncol. pmid:15650886
Papanikolaou A et al. Cholesterol-dependent lipid assemblies regulate the activity of the ecto-nucleotidase CD39. 2005 J. Biol. Chem. pmid:15890655
Guzmán DC et al. Effect of testosterone and steroids homologues on indolamines and lipid peroxidation in rat brain. 2005 J. Steroid Biochem. Mol. Biol. pmid:15857756
Al-Mutair A et al. Cytogenetics and etiology of ambiguous genitalia in 120 pediatric patients. 2004 Sep-Oct Ann Saudi Med pmid:15573851
Schmidt LJ et al. Gene expression in prostate cancer cells treated with the dual 5 alpha-reductase inhibitor dutasteride. 2004 Nov-Dec J. Androl. pmid:15477368
Bairamov AA and Sapronov NS Effect of dehydroepiandrosterone on radioligand binding of [3H]-testosterone by androgen receptors in rat hypothalamus. 2004 Bull. Exp. Biol. Med. pmid:15665952
Finn DA et al. The role of pregnane neurosteroids in ethanol withdrawal: behavioral genetic approaches. 2004 Pharmacol. Ther. pmid:14761701
Namazi MR Further insight into the pathomechanism of acne by considering the 5-alpha-reductase inhibitory effect of linoleic acid. 2004 Int. J. Dermatol. pmid:15357760
Nguyen PN et al. Increased allopregnanolone levels in the fetal sheep brain following umbilical cord occlusion. 2004 J. Physiol. (Lond.) pmid:15331682
Lee HH et al. Theaflavin-3,3'-digallate and penta-O-galloyl-beta-D-glucose inhibit rat liver microsomal 5alpha-reductase activity and the expression of androgen receptor in LNCaP prostate cancer cells. 2004 Carcinogenesis pmid:14963012
Siler U et al. Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model. 2004 FASEB J. pmid:15084515
Assinder SJ et al. Regulation of 5alpha-reductase isoforms by oxytocin in the rat ventral prostate. 2004 Endocrinology pmid:15358676
Ahn KW and Sampson NS Cholesterol oxidase senses subtle changes in lipid bilayer structure. 2004 Biochemistry pmid:14730988
Seo DW et al. Oxysterols from human bile induce apoptosis of canine gallbladder epithelial cells in monolayer culture. 2004 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:15246959
Rontani JF and Aubert C Electron ionization mass spectral fragmentation of derivatized 4,5- and 5,6-epoxysterols. 2004 Rapid Commun. Mass Spectrom. pmid:15116422
Chapple CR Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician. 2004 BJU Int. pmid:15329091
McInnes KJ et al. 5alpha-reduced glucocorticoids, novel endogenous activators of the glucocorticoid receptor. 2004 J. Biol. Chem. pmid:15044432
Frye CA et al. Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 1 5 alpha-reductase. 2004 Brain Res. pmid:15033426
Dalla Valle L et al. Expression of cytochrome P450c17 and other steroid-converting enzymes in the rat kidney throughout the life-span. 2004 J. Steroid Biochem. Mol. Biol. pmid:15261307
Clark RV et al. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. 2004 J. Clin. Endocrinol. Metab. pmid:15126539
McVey MJ et al. Altered testicular microsomal steroidogenic enzyme activities in rats with lifetime exposure to soy isoflavones. 2004 J. Steroid Biochem. Mol. Biol. pmid:15698548
Mathur S et al. Evaluation of cell permeation of a potent 5alpha-reductase inhibitor using MALDI-TOF MS. 2004 J Enzyme Inhib Med Chem pmid:15648657
Palusinski R and Barud W Proscar and propecia--a therapeutic perspective. 2004 J. Clin. Endocrinol. Metab. pmid:15579805
Aissaoui A et al. Novel cationic lipids incorporating an acid-sensitive acylhydrazone linker: synthesis and transfection properties. 2004 J. Med. Chem. pmid:15456264
Zhu HJ and Sacchetti M Solubilization and solid-state characterization of a poorly soluble 5-alpha reductase inhibitor. 2004 Drug Dev Ind Pharm pmid:15285330
Foley CL et al. An update on the use of 5alpha-reductase inhibitors. 2004 Drugs Today pmid:15148530
Hernandez J et al. The potential role of cyclooxygenase-2 inhibitors and 5alpha-reductase inhibitors in the prevention of urologic conditions. 2004 Urol. Clin. North Am. pmid:15123401
Libecco JF and Bergfeld WF Finasteride in the treatment of alopecia. 2004 Expert Opin Pharmacother pmid:15102575
Marberger M et al. Optimising the medical management of benign prostatic hyperplasia. 2004 Eur. Urol. pmid:15041103
Brown GA and Sussman DO A current review of medical therapy for benign prostatic hyperplasia. 2004 J Am Osteopath Assoc pmid:15038398
Gonzales E et al. SRD5B1 (AKR1D1) gene analysis in delta(4)-3-oxosteroid 5beta-reductase deficiency: evidence for primary genetic defect. 2004 J. Hepatol. pmid:15030995
Goodman PJ et al. Implementation of the Prostate Cancer Prevention Trial (PCPT). 2004 Control Clin Trials pmid:15020037
Leyden J et al. A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris. 2004 J. Am. Acad. Dermatol. pmid:14988688
Lemonde HA et al. Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy. 2003 Gut pmid:12970144
Nguyen DH and Taub DD Inhibition of chemokine receptor function by membrane cholesterol oxidation. 2003 Exp. Cell Res. pmid:14597406
Martin RM et al. Familial hyperestrogenism in both sexes: clinical, hormonal, and molecular studies of two siblings. 2003 J. Clin. Endocrinol. Metab. pmid:12843139
Johnson DC and Widlanski TS Cerium(III) chloride-mediated reactions of sulfonamide dianions. 2003 J. Org. Chem. pmid:12816492
Shapiro J and Kaufman KD Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss). 2003 J. Investig. Dermatol. Symp. Proc. pmid:12894990
Nguyen PN et al. Changes in 5alpha-pregnane steroids and neurosteroidogenic enzyme expression in fetal sheep with umbilicoplacental embolization. 2003 Pediatr. Res. pmid:12930920
Torres JM et al. Semiquantitative RT-PCR method coupled to capillary electrophoresis to study 5alpha-reductase mRNA isozymes in rat ventral prostate in different androgen status. 2003 Mol. Cell. Biochem. pmid:12962150
Yoshida T et al. Origin of oxysterols in hepatic bile of patients with biliary infection. 2003 Am. J. Gastroenterol. pmid:14572579
Wang GM et al. Effects of insulin-like growth factor I on steroidogenic enzyme expression levels in mouse leydig cells. 2003 Endocrinology pmid:12959969
Luo J et al. Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma. 2003 Prostate pmid:12949937
Abbiati G et al. Sequential amination/annulation/aromatization reaction of carbonyl compounds and propargylamine: a new one-pot approach to functionalized pyridines. 2003 J. Org. Chem. pmid:12946136
Sasaki G et al. Micropenis and the 5alpha-reductase-2 (SRD5A2) gene: mutation and V89L polymorphism analysis in 81 Japanese patients. 2003 J. Clin. Endocrinol. Metab. pmid:12843198
Faragalla J et al. Comparative pharmacophore development for inhibitors of human and rat 5-alpha-reductase. 2003 J. Mol. Graph. Model. pmid:12798393